Tet2 reshapes the chromatin accessibility of several key TFs at genomic binding regions, including BATF and ETS1 in CD8+tumor-infiltrating lymphocytes, thereby enhancing its anti-tumor immune function and suppressing melanoma growth in vivo. The gene discussed is ETS1; the disease is neoplasm.